CEO ups stake in Bulgarian drug maker Sopharma

Donev acquired the shares through deals on the Bulgarian Stock Exchange on December 6, Sopharma said in a bourse filing.

At the end of September, Donev held a stake of below 5% in Sopharma, according to the company's most recent interim financial statement.

However, Ognyan Donev is indirectly the biggest shareholder in Sopharma, as he controls a 25.39% stake through his company Donev Investments Holding. Donev is also a major shareholder in Sopharma's second biggest shareholder - Telecomplect Invest. Telecomplect Invest controls 20.68% interest in Sopharma.

As at 12:40 CET on Friday, Sopharma shares traded at 3.44 levs, unchanged from their previous closing price on the Bulgarian Stock Exchange.

(1 euro = 1.95583 levs)